Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis.
Since transmission of Chagas' disease by the insect vector is under control in Brazil, transmission by blood transfusion is acquiring special relevance in areas where the disease is endemic and also in countries whose populations are free of infection but that are receiving immigrants from areas where the disease is endemic. Gentian violet, a phenylmethane dye, was the first agent used for the chemical prophylaxis of blood destined for transfusion. A concentration of 0.6 mmol of this dye per liter is effective at eliminating trypomastigotes from blood after 24 h of incubation at 4 degrees C. It is the only effective trypanosomicidal agent available. In the search of alternate compounds, we examined a number of synthetic compounds. They were screened for their activities against blood trypomastigotes of the Y, CL, and B229 strains of Trypanosoma cruzi by using two or more dilutions of each compound. We found that compound Q45, a 6-methoxy-8(diethylaminohexylamino)lepidine dihydrochloride, was highly effective at clearing parasites from infected blood. Doses of 65 and 130 micrograms of this compound eliminated trypomastigotes from blood experimentally contaminated with T. cruzi parasites. These results indicate that Q45 is remarkably active against circulating trypomastigotes. Further studies evaluating Q45 as a prophylactic agent for preventing the transmission of T. cruzi by blood transfusion are of interest.
Chiari
E
E
Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Oliveira
A B
AB
Prado
M A
MA
Alves
R J
RJ
Galvão
L M
LM
Araujo
F G
FG
D000634:Aminoquinolines / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014355:Chagas Disease / Q000469:parasitology / Q000517:prevention & control* / Q000635:transmission*; D004353:Drug Evaluation, Preclinical; D008297:Male; D051379:Mice; D065227:Transfusion Reaction; D014344:Trypanocidal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014349:Trypanosoma cruzi / Q000187:drug effects*
D000634:Aminoquinolines; D000981:Antiprotozoal Agents; D014344:Trypanocidal Agents; C080436:8-aminoquinoline